Medigen Biotechnology Corp. (3176.TWO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Medigen Biotechnology Corp., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -41.54x |
| P/B Ratio | 2.92x |
| P/S Ratio | 2.86x |
| Profitability | |
| Gross Margin | 54.2% |
| Operating Margin | -9.9% |
| Net Margin | -6.9% |
| EBITDA Margin | 1.2% |
| Liquidity | |
| Current Ratio | 4.68x |
| Quick Ratio | 3.90x |
| Leverage | |
| Debt/Equity | 0.61x |
YoY = year-over-year change. Source: FMP..